At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 102 enrolled
Drug / intervention
IPACK blockdrug
Likely dose
IPACK block 20 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following ACL Reconstruction With Bone Patellar Tendon Bone Autograft: A Single Center Randomized Placebo-Controlled Trial
In Brief
A Phase 4 clinical trial evaluating IPACK block for Anterior Cruciate Ligament Rupture. Completed, enrolled 102 participants across 1 site.
Detailed Summary
A randomized, single-blind, single-center study measuring the effects of adductor canal block combined with IPACK infiltration compared to adductor canal block alone on post-operative pain and opioid consumption in patients undergoing ACL reconstruction with Bone Patellar Tendon Bone Autograft
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnterior Cruciate Ligament Rupture
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2023202420252026
First PostedMar 2022
Enrollment StartJul 2022
Primary CompletionMar 2023
Study CompletionDec 2023
TodayJul 2026
First PostedMar 18, 2022
Enrollment StartJul 11, 2022
Primary CompletionMar 31, 2023
Study CompletionDec 18, 2023
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 4.3 years ago
Interventions
IPACK blockdrug
IPACK block with 20 mL of 0.25% Bupivacaine injected into the Interspace between the Popliteal Artery and Capsule of the Knee